Premium
An autopsied case of MV2K + C‐type sporadic Creutzfeldt‐Jakob disease presenting with widespread cerebral cortical involvement and Kuru plaques
Author(s) -
Iwasaki Yasushi,
Saito Yufuko,
Aiba Ikuko,
Kobayashi Atsushi,
Mimuro Maya,
Kitamoto Tetsuyuki,
Yoshida Mari
Publication year - 2017
Publication title -
neuropathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 61
eISSN - 1440-1789
pISSN - 0919-6544
DOI - 10.1111/neup.12350
Subject(s) - kuru , pathology , cerebral cortex , ataxia , thalamus , cerebellum , neuropathology , hyperintensity , cerebellar cortex , medicine , biology , neuroscience , magnetic resonance imaging , disease , scrapie , prion protein , radiology
MV2‐type sporadic Creutzfeldt‐Jakob disease (sCJD), which was previously called “Kuru‐plaque variant”, was gradually revealed to have a wide spectrum and has been classified into three pathological subtypes: MV2K, MV2C and MV2K + C. We herein describe the detailed clinical findings and neuropathologic observations from an autopsied MV2K + C‐type Japanese sCJD case with widespread cerebral cortical pathology and Kuru plaques. In the early stages of the disease, the patient exhibited gait disturbance with ataxia and dysarthria as well as gradual appearance of cognitive dysfunction. Diffusion‐weighted images (DWI) on MRI revealed extensive cerebral cortical hyperintensity. Pathologic investigation revealed extensive spongiform change in the cerebral cortex, particularly in the deeper layers. Vacuole size varied, and some were confluent. Prion protein (PrP) immunostaining revealed extensive PrP deposition in the cerebral cortex, basal ganglia, thalamus, cerebellum, brainstem and spinal cord. In the cerebral cortex, synaptic‐type, Kuru plaque‐like, and coarse plaque‐type PrP depositions were mainly observed, along with some perivacuolar‐type PrP depositions. Kuru plaques and coarse plaque‐type PrP depositions also were observed in the cerebellar cortex. PrP gene analysis revealed no mutations, and polymorphic codon 129 exhibited Met/Val heterozygosity. Western blot analysis revealed a mixture of intermediate‐type PrP Sc and type 2 PrP Sc . Based on previous reports regarding MV2‐type sCJD and the clinicopathologic findings of the present case, we speculated that it may be possible to clinically distinguish each MV2 subtype. Clinical presentation of the MV2K + C subtype includes predominant cerebral cortical involvement signs with ataxia and DWI hyperintensity of the cerebral cortex on MRI.